HELIX WAYFINDER
LIVE

Serial Number

99497202

Owner

Helix, Inc.

Attorney

DEVIN LEE JOSEPH LOOIJEN

First Use Date

Jul 8, 2026

Filing Date

Nov 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HELIX WAYFINDER Trademark

Serial Number: 99497202

HELIX WAYFINDER is a trademark filed by Helix, Inc. on November 14, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Helix, Inc.

400 S El Camino Real
San Mateo, CA 94402

Entity Type: 03

Trademark Details

Filing Date

November 14, 2025

Registration Date

Not Registered

First Use Anywhere

July 8, 2026

First Use in Commerce

July 8, 2026

Goods & Services

Providing health care information by electronic means; Medical testing for diagnostic or treatment purposes; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Software as a service (SAAS) services featuring software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software for clinical interpretation of genetic variants; Providing temporary use of online non-downloadable cloud computing software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics

Filing History

TEAS REQUEST TO DIVIDE RECEIVED
Oct 8, 2026 ERTD
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 16, 2026 GNFN
FINAL REFUSAL E-MAILED
Sep 16, 2026 GNFR
FINAL REFUSAL WRITTEN
Sep 16, 2026 CNFR
USE AMENDMENT ACCEPTED
Sep 16, 2026 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Sep 11, 2026 AUPC
USE AMENDMENT FILED
Sep 11, 2026 IUAF
TEAS AMENDMENT OF USE RECEIVED
Sep 11, 2026 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 23, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 23, 2026 XELR
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 31, 2026 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 31, 2026 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Mar 31, 2026 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 31, 2026 CPEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 14, 2025 MAFR
NEW APPLICATION ENTERED
Nov 14, 2025 NWAP